|
PCM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.983400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.861100E-03 |
| Normal-vs-Stage2 |
3.199300E-03 |
| Normal-vs-Stage3 |
1.195600E-04 |
| Normal-vs-Stage4 |
5.172300E-04 |
| Stage1-vs-Stage2 |
3.389200E-01 |
| Stage1-vs-Stage3 |
9.819700E-02 |
| Stage1-vs-Stage4 |
2.138400E-01 |
| Stage2-vs-Stage3 |
8.198400E-01 |
| Stage2-vs-Stage4 |
9.844400E-01 |
| Stage3-vs-Stage4 |
7.606400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.219100E-04 |
| Normal-vs-AfricanAmerican |
3.643000E-01 |
| Normal-vs-Asian |
2.169900E-02 |
| Caucasian-vs-AfricanAmerican |
1.366850E-01 |
| Caucasian-vs-Asian |
2.490400E-01 |
| AfricanAmerican-vs-Asian |
4.923400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.642080E-04 |
| Normal-vs-Female |
1.861570E-03 |
| Male-vs-Female |
3.743000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.467790E-02 |
| Normal-vs-Age(41-60Yrs) |
6.234700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.351000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.337700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.206800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.854200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.287400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.285400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.368800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.567000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.520400E-02 |
| Classical-VS-Follicular |
7.153900E-04 |
| Classical-VS-Other |
2.404000E-01 |
| Classical-VS-Normal |
1.810290E-02 |
| Tall-VS-Follicular |
8.219200E-01 |
| Tall-VS-Other |
8.754800E-01 |
| Tall-VS-Normal |
6.983200E-04 |
| Follicular-VS-Other |
9.919000E-01 |
| Follicular-VS-Normal |
4.32820000000333E-05 |
| Other-VS-Normal |
3.631900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.167400E-04 |
| Normal-vs-N1 |
7.67390000000479E-05 |
| N0-vs-N1 |
3.439600E-01 |
|
|
